Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs COO✓SelectedUSD · COOGSK vs COO performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs COO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+100.4%
COO return
+40.9%
Excess return
+59.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCOOExcessAlpha
1D-1.3%0.0%-1.4%-1.4%
7D-3.1%-3.5%+0.3%-2.3%
30D-0.9%+4.5%-5.3%-1.9%
3M-4.2%-19.8%+15.6%+0.6%
6M-1.6%-0.3%-1.3%-2.2%
YTD+2.6%-25.9%+28.5%+9.3%
1Y+6.2%-15.9%+22.1%+9.7%
3Y+55.0%-27.9%+82.9%+62.5%
5Y+42.8%-40.0%+82.8%+54.4%
All+100.4%+40.9%+59.5%+74.7%

Cumulative growth

Daily Returns

Daily percentage return beside COO.

Daily Out/Under-Performance

Portfolio return minus COO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × COO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded COO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling